REGENXBIO (RGNX) EV/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 6.00 | 1.10 | 0.78 | -1.16 | -5.31 | -1.08 | ||
| Changes by years, y/y, % | -145% | -82% | -30% | -249% | +358% | -16.8% | |||
REGENXBIO. EV/EBITDA
REGENXBIO. EV/EBITDA, changes, %
REGENXBIO (RGNX) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EV/EBITDA | ? | -1.46 | -1.36 | -4.11 | -5.82 | -1.53 | -1.08 | |
| Changes by years, y/y, % | -306% | -327% | +147% | +380% | +5% | |||
| Changes by quarters, q/q, % | +21% | -7% | +201% | +42% | -74% | |||